HONEY SCHAUMBURG: Open Payments
NPI 1912279290 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$110,609 in 271 payments from 21 companies in 2025. Trend: 2023 $102,156 · 2024 $78,239 · 2025 $110,609
Speaker / faculty: $61,076Travel & lodging: $20,692Consulting: $20,355Food & beverage: $5,237Honoraria: $3,150Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $29,819 |
| Janssen Biotech, Inc. | 41 | $25,682 |
| Arcutis Biotherapeutics, Inc. | 31 | $20,664 |
| UCB, Inc. | 34 | $15,077 |
| Galderma Laboratories, L.P. | 24 | $8,247 |
| Organon LLC | 17 | $4,960 |
| Amgen Inc. | 11 | $3,216 |
| Novartis Pharmaceuticals Corporation | 15 | $1,416 |
| Kowa Pharmaceuticals America, Inc. | 1 | $300 |
| Lilly USA, LLC | 18 | $293 |
Products named: SKYRIZI, Zoryve, TREMFYA, Bimzelx, NEMLUVIO, VTAMA, OTEZLA, DUPIXENT.
Industry payments across AR — which companies pay providers there.
